MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
1 min.Read

OsteoCentric Technologies Introduces THEIR Mechanical Integration UnifiMI Technology to the $7.6b Spinal Fusion Market

Mechanical Integration, the first new method to secure implants to bone since the introduction of osseointegration in the 1970s, is designed to address implant instability in normal and compromised bone

OsteoCentric Technologies, the pioneer of Mechanical Integration, announces the execution of a private label agreement with Altus Spine which will propel their subsidiary, OsteoCentric Spine, LLC, into the pedicle screw fixation space.

The agreement will allow OsteoCentric to marry its Mechanical Integration technology platform, UnifiMITM, to an existing FDA-cleared system.

OsteoCentric Technologies plans to enter the spinal fusion market segment in Q2 2022, and introduce its revolutionary minimally invasive method of instantly securing Pedicle Fastener implants to bone.

This new UnifiMI product launch comes on the heels of announcing the company’s acquisition of the Integrity-SITM Fusion System from Lincotek/Mayo Clinic in October 2021. “Our expansion into spine establishes an additional cornerstone for us as we continue to broaden the Mechanical Integration platform across the spine, sports, total joint reconstruction, extremities, oncology, trauma, veterinary, and dental segments. Our successful conversion of KOL surgeons at dozens of leading Trauma Teaching Centers provides a clear roadmap to achieve the same disruption in the $7.6B US spinal fusion market segment[1],” says Gavin Sontag, Chief Marketing Officer at OsteoCentric.

UnifiMI‘s clinical value, user demand, and market penetration potential have been proven over the last 24 months. With the announcement of this agreement, OsteoCentric plans to prove how quickly and efficiently a standard interference fit implant can be upgraded to a Mechanically Integrated version in the spine space.

“There have been no significant design changes to our method for securing pedicle screws to bone in the last several decades,” says Dr. Kade Huntsman, MD, a board-certified orthopedic surgeon specializing in the treatment of the spine and practicing at St. Mark’s Hospital in Salt Lake City, Utah. “I can attest that the failure of the pedicle screw-bone interface is a common occurrence. Once launched, OsteoCentric’s new method of fixating pedicle screws will be a game-changer that addresses these failures and completely disrupts the market. I am confident it will soon become the new standard of care.”

Additionally, OsteoCentric is pleased to be listed by MedTech Outlook as a Top 10 Orthopedic Solution Provider. The list includes companies that make a significant contribution to the healthcare sector, as well as those that address challenges in treating patients suffering from orthopedic issues.

SourceOsteoCentric Technologies

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

0
Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

0
Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

0
EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

0
The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

0
Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York, No. Carolina
United States
Phone Number: 1.561.316.3330